TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis

Increased inflammation during ageing promotes osteoporosis by activating osteoclast function and inhibiting osteoblasts. Here, the authors show that TGFβ1 release from bone matrix during ageing induces degradation of TRAF3 in mesenchymal progenitor cells, leading to reduced osteoblast differentiatio...

Full description

Bibliographic Details
Main Authors: Jinbo Li, Akram Ayoub, Yan Xiu, Xiaoxiang Yin, James O. Sanders, Addisu Mesfin, Lianping Xing, Zhenqiang Yao, Brendan F. Boyce
Format: Article
Language:English
Published: Nature Publishing Group 2019-06-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-019-10677-0
id doaj-5b2df4499d844e86910a28da5979f452
record_format Article
spelling doaj-5b2df4499d844e86910a28da5979f4522021-05-11T11:44:33ZengNature Publishing GroupNature Communications2041-17232019-06-0110111510.1038/s41467-019-10677-0TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosisJinbo Li0Akram Ayoub1Yan Xiu2Xiaoxiang Yin3James O. Sanders4Addisu Mesfin5Lianping Xing6Zhenqiang Yao7Brendan F. Boyce8Department of Pathology and Laboratory Medicine, University of Rochester Medical CenterDepartment of Pathology and Laboratory Medicine, University of Rochester Medical CenterDepartment of Pathology and Laboratory Medicine, University of Rochester Medical CenterDepartment of Pathology and Laboratory Medicine, University of Rochester Medical CenterDepartment of Orthopaedics and Rehabilitation Medicine, University of Rochester Medical CenterDepartment of Orthopaedics and Rehabilitation Medicine, University of Rochester Medical CenterDepartment of Pathology and Laboratory Medicine, University of Rochester Medical CenterDepartment of Pathology and Laboratory Medicine, University of Rochester Medical CenterDepartment of Pathology and Laboratory Medicine, University of Rochester Medical CenterIncreased inflammation during ageing promotes osteoporosis by activating osteoclast function and inhibiting osteoblasts. Here, the authors show that TGFβ1 release from bone matrix during ageing induces degradation of TRAF3 in mesenchymal progenitor cells, leading to reduced osteoblast differentiation and increased osteoclast formation, and suggesting that pharmacological stabilization of TRAF3 could ameliorate age-related osteoporosis.https://doi.org/10.1038/s41467-019-10677-0
collection DOAJ
language English
format Article
sources DOAJ
author Jinbo Li
Akram Ayoub
Yan Xiu
Xiaoxiang Yin
James O. Sanders
Addisu Mesfin
Lianping Xing
Zhenqiang Yao
Brendan F. Boyce
spellingShingle Jinbo Li
Akram Ayoub
Yan Xiu
Xiaoxiang Yin
James O. Sanders
Addisu Mesfin
Lianping Xing
Zhenqiang Yao
Brendan F. Boyce
TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
Nature Communications
author_facet Jinbo Li
Akram Ayoub
Yan Xiu
Xiaoxiang Yin
James O. Sanders
Addisu Mesfin
Lianping Xing
Zhenqiang Yao
Brendan F. Boyce
author_sort Jinbo Li
title TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
title_short TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
title_full TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
title_fullStr TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
title_full_unstemmed TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
title_sort tgfβ-induced degradation of traf3 in mesenchymal progenitor cells causes age-related osteoporosis
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2019-06-01
description Increased inflammation during ageing promotes osteoporosis by activating osteoclast function and inhibiting osteoblasts. Here, the authors show that TGFβ1 release from bone matrix during ageing induces degradation of TRAF3 in mesenchymal progenitor cells, leading to reduced osteoblast differentiation and increased osteoclast formation, and suggesting that pharmacological stabilization of TRAF3 could ameliorate age-related osteoporosis.
url https://doi.org/10.1038/s41467-019-10677-0
work_keys_str_mv AT jinboli tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
AT akramayoub tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
AT yanxiu tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
AT xiaoxiangyin tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
AT jamesosanders tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
AT addisumesfin tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
AT lianpingxing tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
AT zhenqiangyao tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
AT brendanfboyce tgfbinduceddegradationoftraf3inmesenchymalprogenitorcellscausesagerelatedosteoporosis
_version_ 1721446063186903040